Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Abaxx to Launch Nickel Sulphate Futures on January 10, 2025
-
AIM’s Clinical Strategy Under Incumbent Board Has Totally Failed
-
Prime Drink Group Announces a Massive Production Increase for Glutenberg and its Return to Shelves: Thousands of Outlets in Canada and the U.S. Soon to be Supplied
-
Scilex Bio, a Controlling Interest of Joint Venture by Scilex Holding Company, Reports Phase 2 Trial for Obesity Currently Enrolling with U.S. Patient Cohort to be Added in 2025. Scilex Bio Reports Po
-
Prodege and McDougall Communications Forge Innovative Partnership to Advance Vision Correction Research
-
Global Crossing Airlines Announces Director Resignation
-
Prelude Therapeutics Presents Preliminary Results of Phase 1 Dose-escalation Study of PRT2527 as Monotherapy and in Combination with Zanubrutinib in Patients with Relapsed/Refractory Lymphoid Malignan
-
Reunion Neuroscience Presented RE104 Phase 1 Data at the 2024 American College of Neuropsychopharmacology (ACNP) 63rd Annual Meeting
-
Holding(s) in Company
-
Signature Aviation and Eve Air Mobility to Research Ecosystem Requirements and Services for Advanced Air Mobility Ground Operations
-
ParaZero Announces Significant Order for Drone Safety Systems from a Leading Australian Distributor
-
Beam Ventures announces plans to launch the first gaming-focused venture fund and accelerator in Abu Dhabi
-
Form 8.3 - Volex plc
-
Introducing Cavli CQ10 & CQ20: Compact Cellular IoT Modules for Versatile LTE based Connected Solutions
-
Form 8.3 - Equals Group plc
-
Celcuity Presents Overall Survival Data from Phase 1b Study Evaluating Gedatolisib in Combination with Palbociclib and Endocrine Therapy at the 2024 San Antonio Breast Cancer Symposium
-
Kraig Biocraft Laboratories Reports Record-Setting Recombinant Spider Silk Production in 2024
-
ShorePoint Announces New Partnership with James Madison University Federal Dukes
-
Form 8.3 - Loungers plc
-
Ocugen CEO to Present at Oppenheimer Movers in Rare Disease Summit
-
Aecon to rejoin S&P/TSX Composite Index
-
GEn1E Lifesciences appoints François Nader, MD as Chair of its Board of Directors
-
Giyani Supports and Sponsors Inclusion and Community Empowerment in Kanye
-
Evergold’s DEM Prospect in B.C. Returns High Grades of Antimony in Drilling, Within a Broad System Also Hosting Gold, Silver and Additional Critical Elements
-
Falco Announces Election of Directors and Closing of Its Senior Debt Transactions
-
Join Sebastian Stan on the Red Carpet for Marvel’s Thunderbolts*
-
Simply Good Foods to Report First Quarter Fiscal Year 2025 Financial Results on Thursday, January 9, 2025
-
Monte Rosa Therapeutics Announces Closing of Global License Agreement with Novartis to Advance T and B Cell-modulating VAV1-directed Molecular Glue Degraders
-
Hagersville Battery Energy Storage Park, Ontario: Boralex and partner Six Nations of the Grand River Development Corporation announce the closing of a $538 million financing
-
Bio-Path Holdings Outlines Rationale for Development of BP1001-A as Potential Treatment for Obesity in Type 2 Diabetes Patients
-
Monte Rosa Therapeutics Presents Preclinical Data at the 2024 San Antonio Breast Cancer Symposium on the Potential of its CDK2-directed Molecular Glue Degraders to Treat HR-positive/HER2-negative Brea
-
SmythOS Launches Agent Weaver
-
Nusano to Host Virtual KOL Panel Discussion on December 17, 2024 Previewing the Year Ahead in Radioligand Therapy (RLT)
-
Blink Charging UK and Norfolk County Council to Deliver Next Phase of On-Street EV Charging in Norwich
-
Girard Sharp LLP CASE UPDATE: Embryo Destruction Lawsuit Against CooperSurgical and the Cooper Companies - Court Denies Defendants’ Motions to Dismiss
-
NewGen Signs Binding Term Sheet for Reverse Merger with European Wellness Investment Holdings
-
PolyPid Announces Research and Development Collaboration with ImmunoGenesis Leveraging PLEX Technology to Enhance Cancer Immunotherapy
-
Candel Therapeutics Announces CAN-2409 Achieved Primary Endpoint in Phase 3 Prostate Cancer Trial, Showing Significantly Improved Disease-Free Survival
-
Rafael Holdings Reports First Quarter Fiscal 2025 Financial Results
-
Webuy Global Ltd. Launches Revolutionary Travel AI, Micky1.0, on WhatsApp, Delivering Travel Assistance with Ease and Precision
-
Tecnoglass Sets Record Date for Previously-Announced 36% Increase to Fourth Quarter 2024 Dividend
-
Tilray Canada Launches THC Beverage Holiday Campaign Featuring XMG and Mollo Brands for Festive Season Celebrations
-
Bread Financial Provides Performance Update for November 2024
-
GXO reaches new heights with extension for Guess
-
EsoBiotec Begins Clinical Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
-
OTC Markets Group Welcomes Mongolian Mining Corporation to OTCQX
-
Yara International: Approval of prospectus in connection with bond listing
-
ProQR Therapeutics Announces $8.1 Million in New Funding from Rett Syndrome Research Trust to Expand RNA Editing Collaboration
-
HMNC Brain Health Collaborates with the Austrian Institute of Technology and the Danube Private University to Win Grant from the Austrian Research Promotion Agency
-
EORTC and Immunocore announce enrolment of first patient onto the only active Phase 3 adjuvant trial in uveal melanoma
